VF
LXEO icon

Virtu Financial’s Lexeo Therapeutics LXEO Stock Holding History

Virtu Financial’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,901
Closed -$68K – 1966
2026
Q1 		$68K Buy
+11,901
New +$84.3K ﹤0.01% 1240
2025
Q4 		– Sell
-43,269
Closed -$287K – 1987
2025
Q3 		$287K Buy
+43,269
New +$209K 0.02% 758

Other funds holding LXEO

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Virtu Financial's LXEO Position: Q2 2026 in Review

Virtu Financial sold out of Lexeo Therapeutics (LXEO) in Q2 2026, closing a stake of 11,901 shares — an estimated $68K sold.

Virtu Financial first reported a position in LXEO in Q3 2025 and held it in 2 quarters. The position peaked at $287K in Q3 2025. 141 funds tracked by Wall St. Rank hold LXEO as of Q2 2026.

  • Virtu Financial reported no remaining Lexeo Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 11,901 Lexeo Therapeutics shares in Q2 2026, an estimated $68K.
  • Virtu Financial first reported a position in Lexeo Therapeutics in Q3 2025 and held it in 2 quarters.
  • Virtu Financial's Lexeo Therapeutics position peaked at $287K in Q3 2025.
  • 141 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.